Astrotech Reports Fiscal Year 2024 Financial Results

Stock Information for PharmaCyte Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PharmaCyte Biotech Inc.

Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer
Astrotech Reports Third Quarter of Fiscal Year 2025 Financial Results
1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
Astrotech Creates New Subsidiary EN-SCAN, Inc.
Astrotech Reports Second Quarter of Fiscal Year 2025 Financial Results
Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business
1ST DETECT SECURES FIRST PURCHASE ORDER FOR TSA APPROVED TRACER 1000(TM) ETDs
1st Detect Awarded a Homeland Security Research and Development Contract to Expand the TRACER 1000(TM) Explosive Threat Detection

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.